Skip to main content
. Author manuscript; available in PMC: 2021 Jul 29.
Published in final edited form as: J Med Chem. 2015 May 26;58(11):4610–4623. doi: 10.1021/acs.jmedchem.5b00159

Table 2.

Cytotoxicity, Antiviral, Anti-IN, and Anti-RNase H Activities of Compounds 10x–aa and 11x–aa

graphic file with name nihms-1717707-t0003.jpg
Activity in enzyme assays
IN IC50 (μM)a RNaseH Antiviral activity and cytotoxicity
R X 3’-P ST % in. at 10 μMb IC50 (μM)x EC50(μM)c CC50 (μM)d SIe
10x graphic file with name nihms-1717707-t0004.jpg Et >333 120 19.4 nd >50 ndf
10y graphic file with name nihms-1717707-t0005.jpg Et >333 32 29.7 nd >50 nd
10z graphic file with name nihms-1717707-t0006.jpg Et >333 14 −5.6 nd >50 nd
10aa graphic file with name nihms-1717707-t0007.jpg Et >1000 3.5 4.4 nd >50 nd
11x graphic file with name nihms-1717707-t0008.jpg H >333 <0.45 33.0 nd >50 nd
11y graphic file with name nihms-1717707-t0009.jpg H 18 <0.45 40.7 nd 4.8 >50 >10.4
11z graphic file with name nihms-1717707-t0010.jpg H >1000 16 −2.6 nd >50 nd
11aa graphic file with name nihms-1717707-t0011.jpg H 70 0.40 16.4 nd >50 nd
a

Inhibitory concentration 50% (μM) determined from dose response curves.

b

Percentage of inhibition determined at compound concentration of 10 μM.

c

Effective concentration 50% (μM).

d

Cytotoxic concentration 50% (μM).

e

SI = CC50/EC50.

f

nd: not determined.